Related Experiment Video
Updated: May 15, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
The continued challenge of Staphylococcus aureus in the surgical patient
1Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. dfry@consultmpa.com
Abstract:
Staphylococcus aureus continues to be a common pathogen from community-acquired infections and for infections after surgical procedures. A review of the history of this pathogen indicates that it will likely continue to develop new virulence characteristics and that it will continue to develop new patterns of resistance. This presentation addresses the three major areas for surgeons in the future. First, vancomycin is losing its effectiveness against methicillin-resistant S. aureus (MRSA). The future antibiotic choices for treating this pathogen are discussed. Second, vancomycin is losing its effectiveness for prevention of MRSA infections at the surgical site, and another antibiotic choice needs to be developed for prevention of both methicillin-sensitive and methicillin-resistant staphylococci. Third, decolonization of staphylococci from the nasopharynx is discussed commonly in the literature, but valid evidence for this practice is limited. Controlled clinical trials to prevent surgical site infection by decolonization with mupirocin or other agents are needed. In summary, S. aureus will continue to challenge surgeons as an adaptable pathogen that can defy all of our treatment efforts.
Insights
Staphylococcus aureus challenges surgeons with evolving resistance and virulence. Future strategies must address declining vancomycin effectiveness for treatment and prevention, alongside the need for evidence-based decolonization protocols.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Antimicrobial Resistance
Background:
- Staphylococcus aureus is a persistent pathogen in community and surgical settings.
- The pathogen demonstrates ongoing development of virulence and resistance patterns.
- Methicillin-resistant S. aureus (MRSA) poses a significant clinical challenge.
Purpose of the Study:
- To review the future challenges posed by Staphylococcus aureus for surgeons.
- To discuss evolving antibiotic resistance and treatment efficacy.
- To evaluate current and future strategies for surgical site infection prevention and pathogen decolonization.
Main Methods:
- Literature review and analysis of historical trends in S. aureus infections.
- Discussion of current antibiotic effectiveness, focusing on vancomycin.
- Assessment of evidence for S. aureus decolonization strategies.
Main Results:
- Vancomycin effectiveness is diminishing for both treatment and prevention of MRSA infections.
- Current evidence supporting S. aureus decolonization, particularly from the nasopharynx, is limited.
- New antibiotic agents and validated decolonization protocols are needed.
Conclusions:
- Staphylococcus aureus will continue to adapt, challenging existing treatment and prevention methods.
- Surgeons require novel therapeutic and prophylactic strategies to combat resistant S. aureus strains.
- Further clinical trials are essential to establish effective decolonization practices for surgical patients.
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Asepsis
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
